| Active ingredient (INN) | Tobramycin |
|---|---|
| Brand names | Dbl |
| ATC level 5 | J01GB01 |
| ATC level 4 | J01GB |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Hospira UK Limited, ZENTIVA PHARMA UK LIMITED, BLUMONT PHARMA LIMITED, SUN PHARMACEUTICAL INDUSTRIES EUROPE BV +15 more |
| Registrations on file | 25 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Wockhardt | 300mg | — | 🇦🇺 AU | — | Active |
| TOBRAMYCIN 40 MG/ML SOLUTION FOR INJECTION | 40 MG | injection | 🇬🇧 GB | Hospira UK Limited | Active |
| TOBRAMYCIN 300 MG/5 ML NEBULISER SOLUTION | 300 MG | solution | 🇬🇧 GB | ZENTIVA PHARMA UK LIMITED | Active |
| TOBRAMYCIN 3 MG/ML + DEXAMETHASONE 1 MG/ML EYE DROPS, SUSPENSION | 3 MG | suspension | 🇬🇧 GB | BLUMONT PHARMA LIMITED | Active |
| TOBRAMYCIN 300 MG/ 5 ML NEBULISER SOLUTION | 300 MG | solution | 🇬🇧 GB | SUN PHARMACEUTICAL INDUSTRIES EUROPE BV | Active |
| Tobramycin/Dexamethasone | 3MG | suspension | 🇬🇧 GB | ASPIRE PHARMA LIMITED | Active |
| TOBRAMYCIN 300 MG / 5 ML NEBULISER SOLUTION | 300 MG | solution | 🇬🇧 GB | ALTAN PHARMACEUTICALS SA | Active |
| Tobramycin | 300mg/4mL | solution | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Discontinued |
| Tobramycin | 300mg/5mL | solution | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Discontinued |
| Pfizer TOBRAMYCIN PF | 80 mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| TOBREX tobramycin | 3mg | — | 🇦🇺 AU | Novartis Pharmaceuticals Australia Pty Ltd | Active |
| TOBI tobramycin | 300mg | — | 🇦🇺 AU | Mylan Health Pty Ltd | Active |
| Dbl | 80mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| NEBCIN tobramycin | 80mg | — | 🇦🇺 AU | Aspen Pharmacare Australia Pty Ltd | Active |
| Pfizer TOBRAMYCIN | 80 mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |